Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium.
Calcoen B, Callewaert N, Vandenbulcke A, Kerstens W, Imbrechts M, Vercruysse T, Dallmeier K, Van Weyenbergh J, Maes P, Bossuyt X, Zapf D, Dieckmann K, Callebaut K, Thibaut HJ, Vanhoorelbeke K, De Meyer SF, Maes W, Geukens N. Calcoen B, et al. Among authors: de meyer sf. Viruses. 2022 Jun 9;14(6):1257. doi: 10.3390/v14061257. Viruses. 2022. PMID: 35746728 Free PMC article. Clinical Trial.
Inherited traits affecting platelet function.
Salles II, Feys HB, Iserbyt BF, De Meyer SF, Vanhoorelbeke K, Deckmyn H. Salles II, et al. Among authors: de meyer sf. Blood Rev. 2008 May;22(3):155-72. doi: 10.1016/j.blre.2007.11.002. Epub 2008 Jan 3. Blood Rev. 2008. PMID: 18180086 Review.
Antiplatelet drugs.
De Meyer SF, Vanhoorelbeke K, Broos K, Salles II, Deckmyn H. De Meyer SF, et al. Br J Haematol. 2008 Aug;142(4):515-28. doi: 10.1111/j.1365-2141.2008.07233.x. Epub 2008 May 30. Br J Haematol. 2008. PMID: 18513285 Free article. Review.
Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease.
De Meyer SF, Vandeputte N, Pareyn I, Petrus I, Lenting PJ, Chuah MK, VandenDriessche T, Deckmyn H, Vanhoorelbeke K. De Meyer SF, et al. Arterioscler Thromb Vasc Biol. 2008 Sep;28(9):1621-6. doi: 10.1161/ATVBAHA.108.168369. Epub 2008 Jun 12. Arterioscler Thromb Vasc Biol. 2008. PMID: 18556568 Free article.
Von Willebrand factor: drug and drug target.
De Meyer SF, De Maeyer B, Deckmyn H, Vanhoorelbeke K. De Meyer SF, et al. Among authors: de maeyer b. Cardiovasc Hematol Disord Drug Targets. 2009 Mar;9(1):9-20. doi: 10.2174/187152909787581327. Cardiovasc Hematol Disord Drug Targets. 2009. PMID: 19275573 Review.
von Willebrand factor to the rescue.
De Meyer SF, Deckmyn H, Vanhoorelbeke K. De Meyer SF, et al. Blood. 2009 May 21;113(21):5049-57. doi: 10.1182/blood-2008-10-165621. Epub 2009 Mar 24. Blood. 2009. PMID: 19318682 Free article. Review.
134 results